These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9016913

  • 21. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ, Taaid N, Swerdlow NR.
    Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
    [Abstract] [Full Text] [Related]

  • 22. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S, Neff NH, Hadjiconstantinou M.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):149-57. PubMed ID: 9128833
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G, Rosner AL, Schaub CL.
    J Pharmacol Exp Ther; 1994 Nov 04; 271(2):638-50. PubMed ID: 7965779
    [Abstract] [Full Text] [Related]

  • 26. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M, Yamada K, Nagashima M, Shirakawa K, Furukawa T.
    Pharmacol Biochem Behav; 1995 Nov 04; 52(3):503-8. PubMed ID: 8545466
    [Abstract] [Full Text] [Related]

  • 27. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC, Miller JR, Dohrmann JM, Caine SB.
    Neuropharmacology; 2004 Nov 04; 47 Suppl 1():256-73. PubMed ID: 15464142
    [Abstract] [Full Text] [Related]

  • 28. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA, Himmler C, Bonta T, Rice LL.
    Psychopharmacology (Berl); 1998 Dec 04; 140(4):387-97. PubMed ID: 9888612
    [Abstract] [Full Text] [Related]

  • 29. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
    Barik S, de Beaurepaire R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun 04; 29(5):718-26. PubMed ID: 15913875
    [Abstract] [Full Text] [Related]

  • 30. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):237-41. PubMed ID: 7988649
    [Abstract] [Full Text] [Related]

  • 31. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
    Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani A.
    J Psychopharmacol; 2003 Dec 01; 17(4):415-23. PubMed ID: 14870954
    [Abstract] [Full Text] [Related]

  • 32. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
    Rehders JH, Löscher W, Richter A.
    Neuroscience; 2000 Dec 01; 97(2):267-77. PubMed ID: 10799758
    [Abstract] [Full Text] [Related]

  • 33. Mediation of rat postejaculatory 22 kHz ultrasonic vocalization by dopamine D2 receptors.
    Cagiano R, Barfield RJ, White NR, Pleim ET, Cuomo V.
    Pharmacol Biochem Behav; 1989 Sep 01; 34(1):53-8. PubMed ID: 2576313
    [Abstract] [Full Text] [Related]

  • 34. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE, Hood CA, Heidema AM.
    Behav Pharmacol; 1999 Dec 01; 10(8):717-22. PubMed ID: 10780286
    [Abstract] [Full Text] [Related]

  • 35. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 36. Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
    Bordet R, Ridray S, Schwartz JC, Sokoloff P.
    Eur J Neurosci; 2000 Jun 01; 12(6):2117-23. PubMed ID: 10886351
    [Abstract] [Full Text] [Related]

  • 37. D1 dopamine receptor activity of anti-parkinsonian drugs.
    Fici GJ, Wu H, VonVoigtlander PF, Sethy VH.
    Life Sci; 1997 Jun 01; 60(18):1597-603. PubMed ID: 9126882
    [Abstract] [Full Text] [Related]

  • 38. Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.
    Gleason SD, Witkin JM.
    Behav Pharmacol; 2004 Feb 01; 15(1):85-9. PubMed ID: 15075630
    [Abstract] [Full Text] [Related]

  • 39. Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats.
    Cohen C, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1998 Dec 01; 140(4):478-85. PubMed ID: 9888624
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958.
    Meloni EG, Davis M.
    Psychopharmacology (Berl); 1999 Jun 01; 144(4):373-80. PubMed ID: 10435410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.